Gejman RS, Chang AY, Jones HF, DiKun K, Hakimi AAri, Schietinger A, Scheinberg DA.  2018.  Rejection of immunogenic tumor clones is limited by clonal fraction.. Elife. 7

Ott PA, Hu Z, Keskin DB, Shukla SA, Sun J, Bozym DJ, Zhang W, Luoma A, Giobbie-Hurder A, Peter L et al..  2017.  An immunogenic personal neoantigen vaccine for patients with melanoma.. Nature. 547(7662):217-221.

Chang AY, Dao T, Gejman RS, Jarvis CA, Scott A, Dubrovsky L, Mathias MD, Korontsvit T, Zakhaleva V, Curcio M et al..  2017.  A therapeutic T cell receptor mimic antibody targets tumor-associated PRAME peptide/HLA-I antigens.. J Clin Invest. 127(7):2705-2718.

Blachere NE, Orange DE, Santomasso BD, Doerner J, Foo PK, Herre M, Fak J, Monette S, Gantman EC, Frank MO et al..  2014.  T cells targeting a neuronal paraneoplastic antigen mediate tumor rejection and trigger CNS autoimmunity with humoral activation.. Eur J Immunol. 44(11):3240-51.

Diab A, Jenq RR, Rizzuto GA, Cohen AD, Huggins DW, Merghoub T, Engelhorn ME, Guevara-Patiño JA, Suh D, Hubbard-Lucey VM et al..  2013.  Enhanced responses to tumor immunization following total body irradiation are time-dependent.. PLoS One. 8(12):e82496.